Green Cross Holdings Corporation (KRX:005250)

Market Cap	698.28B
Revenue (ttm)	2.40T
Net Income (ttm)	128.05B
Shares Out	45.40M
EPS (ttm)	2,821.33
PE Ratio	5.45
Forward PE	n/a
Dividend	500.00 (3.20%)
Ex-Dividend Date	Dec 27, 2024

Volume	76,082
Average Volume	98,378
Open	15,530
Previous Close	15,380
Day's Range	15,500 - 16,060
52-Week Range	12,000 - 18,050
Beta	0.70
RSI	50.89
Earnings Date	Nov 14, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250